Prepare for Launch: Ensuring your Spray-Dried Inhalation Product is Commercial Ready

Winning the Hand You’re Dealt: An Interactive Workshop on Developing Innovative Spray-Dried Products

Development and Characterization of Inhalable Microparticles Co-Delivering Nintedanib and Metformin for Idiopathic Pulmonary Fibrosis

In Vitro Performance of a Mannitol-Based Spray-Dried Powder Combined with Quattrii Carrier Free Dry Powder Inhaler

In Vitro Performance Assessment of Fluticasone Propionate/Salmeterol Xinafoate Blends Developed for a Capsule-Based Device

Screening of Capsule-Filling Process Parameters in the Development of Spray-Dried Powder Products for Pulmonary Delivery

Determining Material Composition of Fines-Only Formulations Through X-Ray Computed Tomography

Design of Spray-Dried Glucagon-Like Peptide-1 Exenatide Microparticles for Pulmonary Delivery: A Room-Temperature Stable Formulation of an Oxidation Sensitive Peptide

Powder Rheology for Batch Comparison During Manufacturing

Excipient Effects on Spray-Dried Antibody Stability: A Comparative Study

Replacing Sugar Excipient with Polymyxins to Improve Dosing of a Dry Powder Teixobactin-Lipopeptide Hybrid for the Treatment of Pulmonary Infections

Optimization of Spray-Dried Spectinamide Lee1810 Inhalation Powders

Development and Evaluation of Inhalable Imipenem Dry Powder for Treating Pulmonary Pseudomonas aeruginosa Infections

A Distribution-Based Metric for Quantifying Dispersibility in Dry Powder Inhalers

Development of PEGylated DNase for Nebulization

Influence of L-Leucine Content on the Internal and External Morphology of Spray-Dried Particles

Tobramycin-Synthetic Lung Surfactant Dry Powder for Treatment of Pseudomonas aeruginosa-Induced Lung Infection in Rats

Achieving Improved Lung Delivery of Synthetic Lung Surfactant Excipient Enhanced Growth Dry Powder Aerosol Formulations in Neonates

PEGylated Ciprofloxacin Liposomal Dry Powder: Efficacy in Acute Rat Pseudomonas aeruginosa-Induced Lung Infection

Impact of Spray-Dryer Technology on the Aerosol Performance and Physicochemical Properties of Synthetic Dipalmitoylphosphatidylcholine Dry Powder Formulations

Development of an Inhalation-Assisted Pediatric Dry Powder Inhaler and Synthetic Lung Surfactants Excipient Enhanced Growth Platform for Anti-Infective Aerosol Delivery

Investigating Effects of Single Prong Nasal Interface Orifice Diameter and Capillary-to-Orifice Distance on Air Jet Dry Power Inhaler Plume Properties and Performance